MBX is trading at $57.54 (4.2% up) today, driven by recent news of Paradigm Biocapital Advisors LP's significant stake acquisition and positive analyst attention. - Paradigm Biocapital Advisors LP acquired over 2.4 million shares of MBX Biosciences in mid-June, with the news reported on June 30, contributing to a substantial stock price increase since the transaction. - The company also recently hit an all-time high of $54.98, supported by analyst upgrades and a prevailing "Buy" consensus from multiple Wall Street firms.